Intraoperative specimens taken from her during debridement cultured group A Streptococcus
Erythromycin resistance in Group A Streptococcus
(GAS) has increased in prevalence over the past several years.
The findings provide the first evidence in humans that this type of vaccine can induce immune responses that will protect against multiple group A streptococcus
serotypes without eliciting antibodies that cross-react with human tissues, they said.
According to data obtained from the Centers for Disease Control and Prevention (CDC), these serotypes are believed to be responsible for causing the vast majority of group A streptococcus
related diseases in North America.
With the support of the National Institute of Allergy and Infectious Diseases, scientists have determined the genetic sequence, or DNA code, for more than 95 percent of the group A streptococcus
The report includes a compilation of currently active projects in development of vaccines targeting pneumococcus (Streptococcus pneumoniae), Group A Streptococcus
(GAS) or Group B Streptococcus (GBS) for prophylaxis of streptococcal infections.
High-resolution genotyping elucidates the epidemiology of group A streptococcus
According to the US Centers for Disease Control and Prevention (CDC) these serotypes are believed to be responsible for causing the vast majority of group A streptococcus
The report includes a compilation of currently active projects in development of vaccines and antibodies targeting pneumococcus (Streptococcus pneumoniae), Group A Streptococcus
(GAS) or Group B Streptococcus (GBS) for prophylaxis and treatment of streptococcal infections.
Streptococcus pyogenes had grown resistant to erythromycin, an antibiotic commonly prescribed for people who are allergic to penicillin but who have a respiratory or skin infection caused by group A streptococcus
SAN DIEGO, March 28 /PRNewswire/ -- The Gen-Probe Group A Streptococcus
Direct Test (GASD), shown to provide accurate and rapid identification of Streptococcus pyogenes from throat swabs, has been cleared for market release by the Food and Drug Administration.
The OIA product line includes tests for Group A Streptococcus
, Influenza A and B, Chlamydia, Group B Streptococcus, Respiratory Syncytial Virus (RSV), and Clostridium difficile Toxin A.
Swabs from institution residents and staff were plated onto blood agar, with group A streptococcus
identified by [beta]-hemolysis and Lancefield typing using standard commercially available latex agglutination methods, as described elsewhere (16).
The bacterium engendering such interest these days is Streptococcus pyogenes, or group A streptococcus
An attack of body tissues by antibodies against group A Streptococcus
bacteria is believed to cause rheumatic fever, though the exact mechanism has yet to be identified.